Weekly cisplatin fails to show fewer serious side effects in… | HappeningNow.news

Health · 41 views

Weekly cisplatin fails to show fewer serious side effects in p16-negative head and neck cancer

Physicians typically use either a higher dose of cisplatin given every three weeks or a lower dose given weekly in combination with radiation to treat locally advanced head and neck cancer.

Source Summary Published October 4, 2026 Brief Under 1 min brief
Story intelligence
Coverage Single outlet Single-outlet story
Views 41 Community interest
Brief read Under 1 min brief 80 words

Summary

Physicians typically use either a higher dose of cisplatin given every three weeks or a lower dose given weekly in combination with radiation to treat locally advanced head and neck cancer. However, before NRG-HN009, there was limited randomized evidence to determine which regimen provided the best balance of cancer control and treatment-related side effects. This question is particularly important for patients with p16-negative disease, who often have multiple other health conditions and may have a lower tolerance for intensive chemoradiation.

Read original at Medical Xpress

More from Health

Continue reading recent Health coverage

Support HappeningNow

Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.

Support HappeningNow

Report an issue with this page